Inari Medical, Inc.
NARI · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2,407 | $2,918 | $2,734 | $3,742 |
| - Cash | $41 | $70 | $67 | $39 |
| + Debt | $33 | $33 | $31 | $32 |
| Enterprise Value | $2,399 | $2,881 | $2,698 | $3,735 |
| Revenue | $153 | $146 | $143 | $132 |
| % Growth | 5.2% | 1.8% | 8.4% | – |
| Gross Profit | $134 | $122 | $124 | $114 |
| % Margin | 87.1% | 83.9% | 86.8% | 86.3% |
| EBITDA | -$7 | -$17 | -$11 | -$1 |
| % Margin | -4.7% | -11.4% | -8% | -0.7% |
| Net Income | -$18 | -$31 | -$24 | -$5 |
| % Margin | -12% | -21.5% | -16.9% | -3.5% |
| EPS Diluted | -0.31 | -0.54 | -0.42 | -0.081 |
| % Growth | 42.6% | -28.6% | -418.5% | – |
| Operating Cash Flow | $3 | $12 | -$12 | $12 |
| Capital Expenditures | -$4 | -$5 | -$2 | -$2 |
| Free Cash Flow | -$1 | $7 | -$14 | $10 |